Article Information
History
- June 2, 2020.
Article Versions
- Version 1 (April 21, 2020 - 02:36).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jinkun Chen1,§,
- Evann E. Hilt2,§,
- Huan Wu3,
- Zhuojing Jiang1,
- QinChao Zhang1,
- JiLing Wang1,
- Yifang Wang3,
- Fan Li4,
- Ziqin Li5,
- Jialiang Tang1,* and
- Shangxin Yang2,5,*
- 1Shaoxing Center for Disease Control and Prevention, Shaoxing, Zhejiang, China
- 2Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, CA, USA
- 3IngeniGen XunMinKang Biotechnology Inc., Shaoxing, Zhejiang, China
- 4Three Coin Analytics, Inc. Pleasanton, CA, USA
- 5Zhejiang-Californina International Nanosystems Institute, Zhejiang University, Hangzhou, Zhejiang, China
- ↵* Corresponding authors: Jialiang Tang: 992488904{at}qq.com; Shangxin Yang, PhD, D(ABMM): shangxinyang{at}mednet.ucla.edu
↵§ Authors contributed equally.
Posted June 02, 2020.
Epidemiological and Genomic Analysis of SARS-CoV-2 in Ten Patients from a Mid-sized City outside of Hubei, China in the Early Phase of the COVID-19 Outbreak
